AHFS Injectable Drug Information
ASHP’s New and Expanded Guide to IV Compatibility & Stability
For more than 40 years ASHP has published the most trusted resource for injectable drug information. Our new ASHP® Injectable Drug InformationTM now delivers the same high-quality content that you can expect from ASHP with even MORE of the information you need to make decisive patient care decisions.
ASHP® Injectable Drug InformationTM 2021 now comes complete with 2 years of digital interactive access and a print edition to ensure you have constant, uninterrupted access. The digital content is interactive, mobile, and updated quarterly. Your 2 years of digital interactive access also includes linked monographs to Extended Stability for Parenteral Drugs, forming a single, comprehensive resource on injectable drug information. Current 2021 edition features 18 new monographs and nearly 200 new references for a total of over 24,000 total compatibility pairs.
Official Methods of Analysis
ASHP’s New and Expanded Guide to IV Compatibility & Stability
For more than 40 years ASHP has published the most trusted resource for injectable drug information. Our new ASHP® Injectable Drug InformationTM now delivers the same high-quality content that you can expect from ASHP with even MORE of the information you need to make decisive patient care decisions.
ASHP® Injectable Drug InformationTM 2021 now comes complete with 2 years of digital interactive access and a print edition to ensure you have constant, uninterrupted access. The digital content is interactive, mobile, and updated quarterly. Your 2 years of digital interactive access also includes linked monographs to Extended Stability for Parenteral Drugs, forming a single, comprehensive resource on injectable drug information. Current 2021 edition features 18 new monographs and nearly 200 new references for a total of over 24,000 total compatibility pairs.
Oral Lipd-Based Formulations
Enhancing the Bioavailablility of Poorly Water-Soluble Drugs
Water-Insoluble Drug Formulation
Properties and Formulation: From Theory to Real-World Application
Scientists have attributed more than 40 percent of the failures in new drug development to poor biopharmaceutical properties, particularly water insolubility. Issues surrounding water insolubility can postpone or completely derail important new drug development. Even the much-needed reformulation of currently marketed products can be significantly affected by these challenges. More recently it was reported that the percentage increased to 90% for the candidates of new chemical entities in the discovery stage and 75% for compounds under development.
In the most comprehensive resource on the topic, this third edition of Water-Insoluble Drug Formulation brings together a distinguished team of experts to provide the scientific background and step-by-step guidance needed to deal with solubility issues in drug development. Twenty-three chapters systematically describe the detailed discussion on solubility theories, solubility prediction models, the aspects of preformulation, biopharmaceutics, pharmacokinetics, regulatory, and discovery support of water-insoluble drugs to various techniques used in developing delivery systems for water-insoluble drugs. This book includes more than 15 water-insoluble drug delivery systems or technologies, illustrated with case studies and featuring oral and parenteral applications. Highlighting the most current information and data available, this seminal volume reflects the significant progress that has been made in nearly all aspects of this field.
The aim of this book is to provide a handy reference for pharmaceutical scientists in the handling of formulation issues related to water-insoluble drugs. In addition, this book may be useful to pharmacy and chemistry undergraduate students and pharmaceutical and biopharmaceutical graduate students to enhance their knowledge in the techniques of drug solubilization and dissolution enhancement.
